Chiari Malformation
9
1
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Clinical Study of the Treatment of Chiari Malformation Combined With Type II Skull Base Depression
MiDura-Study (Neuro-Patch in Duraplasty)
Development of a Patient-reported Outcome Measure for Chiari Malformation and Syringomyelia
Examining Different Components of Online Acceptance and Commitment Therapy for People With Chiari Malformation
Dural Graft Equivalent Comparison Trial
Online Acceptance and Commitment Therapy for Chronic Pain in Sample of People With Chiari Malformation
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
Comparison of Four Questionnaires for OSA Screening in China
Duragen Versus Duraguard in Chiari Surgery